Publication
The benefit of macrolide therapy in patients with pneumococcal pneumonia is only present in patients with bacteremia
| dc.contributor.author | Gonçalves-Pereira, J. | |
| dc.contributor.author | Costa, L. | |
| dc.contributor.author | Silva, I. | |
| dc.contributor.author | Simões, A. | |
| dc.contributor.author | Froes, F. | |
| dc.contributor.author | Mergulhão, P. | |
| dc.contributor.author | Varela Ramos, P. | |
| dc.contributor.author | Leal, D. | |
| dc.contributor.author | Alves, R. | |
| dc.contributor.author | Custódio, M. | |
| dc.contributor.author | Gomes, A. | |
| dc.date.accessioned | 2023-05-28T10:45:04Z | |
| dc.date.available | 2023-05-28T10:45:04Z | |
| dc.date.issued | 2023 | |
| dc.description.sponsorship | This work was supported by a research grant from Merck Sharp & Dohme Corp., a division of Merck & Co., Inc., Kenilworth, NJ, USA [IIS# 60150] under the Investigator Studies Program. The content of this publication reflects only the views of the authors. The sponsor had no role in the analyses or interpretation of the data. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.doi | 10.1016/j.pulmoe.2022.08.003 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.26/44916 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | macrolide | pt_PT |
| dc.subject | pneumonia | pt_PT |
| dc.subject | bacteremia | pt_PT |
| dc.title | The benefit of macrolide therapy in patients with pneumococcal pneumonia is only present in patients with bacteremia | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 256 | pt_PT |
| oaire.citation.issue | 3 | pt_PT |
| oaire.citation.startPage | 253 | pt_PT |
| oaire.citation.title | Pulmonology | pt_PT |
| oaire.citation.volume | 29 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |